Connect with us
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.


Scientific Industries Announces Appointment of Dr. Jürgen Schumacher to the Board of Directors


BOHEMIA, N.Y. and PITTSBURGH, April 30, 2021 /PRNewswire/ — Scientific Industries, Inc. (OTCQB: SCND) today announced the appointment of Dr. Jürgen Schumacher to the Company's Board of Directors.

Dr. Jürgen Schumacher is an internationally recognized German entrepreneur with more than 35 years of expertise in the biotech industry. Dr. Schumacher co-founded Qiagen AG, one of Germany's largest biotechnology companies, NewLab Bioquality AG, which was acquired by Charles River Laboratories International Inc., BiBiTech and Algiax Pharmaceuticals.  Dr. Schumacher advises and invests in promising biotech business models.

Dr. Schumacher holds a PhD in Biology from Heinrich Heine University of Düsseldorf and a Diploma in Biology from Technical University of Darmstadt.

John Moore, Chairman of Scientific Industries and President of Scientific Bioprocessing, Inc. (SBI), said, “We are delighted to welcome Dr. Schumacher as director on Scientific Industries' Board. Jürgen has built a distinguished career within the biotechnology industry and his extensive industry knowledge and experience will be a real asset to the Board. We look forward to working with him in the successful combination of aquila biolabs and Scientific Bioprocessing to create a new digital platform that brings dramatic innovation to bioprocessing and significantly enhances accuracy for improved time-to-market.”

About Scientific Bioprocessing, Inc. (SBI)
SBI is dedicated to providing state-of-the-art instruments, strategies, and technologies to expedite the production of viable cells and therapies with a streamlined process and product consistency. SBI's mission is to develop sensor technologies and instruments that make cell culture and bioprocessing work easier, experiments more reproducible, and culture conditions better suited to meet experimental objectives. SBI is a subsidiary of Scientific Industries, Inc.  To learn more, visit

About Scientific Industries, Inc.
Scientific Industries (OTCQB:SCND),  is a life science tool provider. It designs, manufactures, and markets laboratory equipment, including the world-renowned Vortex-Genie® 2 Mixer and Torbal® balances, and bioprocessing systems and methods. Scientific Industries' products are generally used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies. To learn more, visit

Safe Harbor Statement
Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company's Securities and Exchange Commission reports, including our annual report on Form 10-K.

Sandy Williams
Marketing and Product Manager
Scientific Bioprocessing, Inc.

Investor Contact:
Joe Dorame
Lytham Partners, LLC
Phone: (602) 889-9700 

Cision View original content to download multimedia:

SOURCE Scientific Industries, Inc.

Editorial & Advertiser disclosure

Call for Entries

Global Banking and Finance Review Awards Nominations 2022
2022 Awards now open. Click Here to Nominate

Newsletters with Secrets & Analysis. Subscribe Now


Global Banking & Finance Review® is a leading financial portal and Print Magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management. Copyright © 2010-2021 GBAF Publications Ltd - All Rights Reserved.